298 related articles for article (PubMed ID: 21045151)
21. Differences in expression of the cancer stem cell marker aldehyde dehydrogenase 1 among estrogen receptor-positive/human epidermal growth factor receptor type 2-negative breast cancer cases with early, late, and no recurrence.
Miyoshi Y; Shien T; Ogiya A; Ishida N; Yamazaki K; Horii R; Horimoto Y; Masuda N; Yasojima H; Inao T; Osako T; Takahashi M; Tomioka N; Endo Y; Hosoda M; Doihara H; Miyoshi S; Yamashita H;
Breast Cancer Res; 2016 Jul; 18(1):73. PubMed ID: 27368476
[TBL] [Abstract][Full Text] [Related]
22. MiR-146a promotes the asymmetric division and inhibits the self-renewal ability of breast cancer stem-like cells via indirect upregulation of Let-7.
Liang R; Li Y; Wang M; Tang SC; Xiao G; Sun X; Li G; Du N; Liu D; Ren H
Cell Cycle; 2018; 17(12):1445-1456. PubMed ID: 29954239
[TBL] [Abstract][Full Text] [Related]
23. Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling.
Sullivan JP; Spinola M; Dodge M; Raso MG; Behrens C; Gao B; Schuster K; Shao C; Larsen JE; Sullivan LA; Honorio S; Xie Y; Scaglioni PP; DiMaio JM; Gazdar AF; Shay JW; Wistuba II; Minna JD
Cancer Res; 2010 Dec; 70(23):9937-48. PubMed ID: 21118965
[TBL] [Abstract][Full Text] [Related]
24. Cucurbitacin I suppressed stem-like property and enhanced radiation-induced apoptosis in head and neck squamous carcinoma--derived CD44(+)ALDH1(+) cells.
Chen YW; Chen KH; Huang PI; Chen YC; Chiou GY; Lo WL; Tseng LM; Hsu HS; Chang KW; Chiou SH
Mol Cancer Ther; 2010 Nov; 9(11):2879-92. PubMed ID: 21062915
[TBL] [Abstract][Full Text] [Related]
25. Germline genetic variants disturbing the Let-7/LIN28 double-negative feedback loop alter breast cancer susceptibility.
Chen AX; Yu KD; Fan L; Li JY; Yang C; Huang AJ; Shao ZM
PLoS Genet; 2011 Sep; 7(9):e1002259. PubMed ID: 21912531
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of c-Myc by let-7b mimic reverses mutidrug resistance in gastric cancer cells.
Yang X; Cai H; Liang Y; Chen L; Wang X; Si R; Qu K; Jiang Z; Ma B; Miao C; Li J; Wang B; Gao P
Oncol Rep; 2015 Apr; 33(4):1723-30. PubMed ID: 25633261
[TBL] [Abstract][Full Text] [Related]
27. Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer.
Charafe-Jauffret E; Ginestier C; Iovino F; Tarpin C; Diebel M; Esterni B; Houvenaeghel G; Extra JM; Bertucci F; Jacquemier J; Xerri L; Dontu G; Stassi G; Xiao Y; Barsky SH; Birnbaum D; Viens P; Wicha MS
Clin Cancer Res; 2010 Jan; 16(1):45-55. PubMed ID: 20028757
[TBL] [Abstract][Full Text] [Related]
28. The expression pattern of aldehyde dehydrogenase 1 (ALDH1) is an independent prognostic marker for low survival in colorectal tumors.
Vogler T; Kriegl L; Horst D; Engel J; Sagebiel S; Schäffauer AJ; Kirchner T; Jung A
Exp Mol Pathol; 2012 Feb; 92(1):111-7. PubMed ID: 22101256
[TBL] [Abstract][Full Text] [Related]
29. LIN28 Expression in malignant germ cell tumors downregulates let-7 and increases oncogene levels.
Murray MJ; Saini HK; Siegler CA; Hanning JE; Barker EM; van Dongen S; Ward DM; Raby KL; Groves IJ; Scarpini CG; Pett MR; Thornton CM; Enright AJ; Nicholson JC; Coleman N;
Cancer Res; 2013 Aug; 73(15):4872-84. PubMed ID: 23774216
[TBL] [Abstract][Full Text] [Related]
30. Disturbance of the let-7/LIN28 double-negative feedback loop is associated with radio- and chemo-resistance in non-small cell lung cancer.
Yin J; Zhao J; Hu W; Yang G; Yu H; Wang R; Wang L; Zhang G; Fu W; Dai L; Li W; Liao B; Zhang S
PLoS One; 2017; 12(2):e0172787. PubMed ID: 28235063
[TBL] [Abstract][Full Text] [Related]
31. High expression of CD109 antigen regulates the phenotype of cancer stem-like cells/cancer-initiating cells in the novel epithelioid sarcoma cell line ESX and is related to poor prognosis of soft tissue sarcoma.
Emori M; Tsukahara T; Murase M; Kano M; Murata K; Takahashi A; Kubo T; Asanuma H; Yasuda K; Kochin V; Kaya M; Nagoya S; Nishio J; Iwasaki H; Sonoda T; Hasegawa T; Torigoe T; Wada T; Yamashita T; Sato N
PLoS One; 2013; 8(12):e84187. PubMed ID: 24376795
[TBL] [Abstract][Full Text] [Related]
32. Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer.
Landen CN; Goodman B; Katre AA; Steg AD; Nick AM; Stone RL; Miller LD; Mejia PV; Jennings NB; Gershenson DM; Bast RC; Coleman RL; Lopez-Berestein G; Sood AK
Mol Cancer Ther; 2010 Dec; 9(12):3186-99. PubMed ID: 20889728
[TBL] [Abstract][Full Text] [Related]
33. ALDH1 as a functional marker of cancer stem and progenitor cells.
Douville J; Beaulieu R; Balicki D
Stem Cells Dev; 2009; 18(1):17-25. PubMed ID: 18573038
[TBL] [Abstract][Full Text] [Related]
34. Embryonic stem cell microRNAs: defining factors in induced pluripotent (iPS) and cancer (CSC) stem cells?
Gunaratne PH
Curr Stem Cell Res Ther; 2009 Sep; 4(3):168-77. PubMed ID: 19492978
[TBL] [Abstract][Full Text] [Related]
35. LIN28: A cancer stem cell promoter for immunotherapy in head and neck squamous cell carcinoma.
Li M; Chen H; Wu T
Oral Oncol; 2019 Nov; 98():92-95. PubMed ID: 31574415
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells.
Lo WL; Yu CC; Chiou GY; Chen YW; Huang PI; Chien CS; Tseng LM; Chu PY; Lu KH; Chang KW; Kao SY; Chiou SH
J Pathol; 2011 Mar; 223(4):482-95. PubMed ID: 21294122
[TBL] [Abstract][Full Text] [Related]
37. Aldehyde Dehydrogenase 1 (ALDH1) Promotes the Toxicity of TRAIL in Non-Small Cell Lung Cancer Cells via Post-Transcriptional Regulation of MEK-1 Expression.
Tian S; Liu DH; Wang D; Ren F; Xia P
Cell Physiol Biochem; 2018; 51(1):217-227. PubMed ID: 30448845
[TBL] [Abstract][Full Text] [Related]
38. Co-expression of stem cell markers ALDH1 and CD44 in non-malignant and neoplastic lesions of the breast.
DA Cruz Paula A; Marques O; Rosa AM; DE Fátima Faria M; Rêma A; Lopes C
Anticancer Res; 2014 Mar; 34(3):1427-34. PubMed ID: 24596390
[TBL] [Abstract][Full Text] [Related]
39. Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells.
Li Y; Zhang T; Korkaya H; Liu S; Lee HF; Newman B; Yu Y; Clouthier SG; Schwartz SJ; Wicha MS; Sun D
Clin Cancer Res; 2010 May; 16(9):2580-90. PubMed ID: 20388854
[TBL] [Abstract][Full Text] [Related]
40. Synergistic activity of sorafenib and sulforaphane abolishes pancreatic cancer stem cell characteristics.
Rausch V; Liu L; Kallifatidis G; Baumann B; Mattern J; Gladkich J; Wirth T; Schemmer P; Büchler MW; Zöller M; Salnikov AV; Herr I
Cancer Res; 2010 Jun; 70(12):5004-13. PubMed ID: 20530687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
